First-line treatment of driver gene-negative metastatic lung adenocarcinoma with malignant pleural effusion: Should chemotherapy be combined with an immune checkpoint inhibitor or bevacizumab?
Article in Investigational New Drugs (February 2024)
The most recent citing publications are shown below. View all 4 publications that cite this research output on Dimensions.
First-line treatment for driver gene–negative metastatic lung adenocarcinoma with malignant pleural effusion: Should chemotherapy be combined with an immune checkpoint inhibitor or bevacizumab?
Preprint in Research Square (September 2023)
Screening biomarkers for predicting the efficacy of immunotherapy in patients with PD-L1 overexpression
Article in Journal of Cancer Research and Clinical Oncology (July 2023)